AU Stock MarketDetailed Quotes

TYP Tryptamine Therapeutics Ltd

Watchlist
  • 0.044
  • +0.004+10.00%
20min DelayTrading Dec 4 13:44 AET
56.16MMarket Cap-483P/E (Static)

Tryptamine Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tryptamine Therapeutics Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Tryptamine Therapeutics Ltd Earnings Reports

  • Tryptamine Therapeutics Ltd: Annual Report to shareholders

    Sep 30 04:21 ET

  • Tryptamine Therapeutics Ltd: Preliminary Final Report Reporting Adjustments

    Sep 30 04:16 ET

  • Tryptamine Therapeutics Ltd: Appendix 4E Preliminary Final Report

    Aug 29 19:29 ET

    • Trending AU Stocks
    ASX High Dividend ASX High Dividend
    Symbol Mini Chart % Chg
    Fortescue Ltd
    FMG
    +1.49%
    Rio Tinto Ltd
    RIO
    +0.56%
    BHP Group Ltd
    BHP
    +0.37%
    Woodside Energy Group Ltd
    WDS
    -0.20%
    Telstra Group Ltd
    TLS
    -0.13%

    Unlock the Full List